Host-Directed Therapies for Tuberculosis

Overview

Journal Cold Spring Harb Perspect Med

Specialty General Medicine

Date 2015 May 20

PMID 25986592

Citations 53

Authors

David M Tobin

Affiliations

Soon will be listed here.

Abstract

Host-directed therapies are a relatively new and promising approach to treatment of tuberculosis. Modulation of specific host immune pathways, including those that impact inflammation and immunopathology, can limit mycobacterial infection and pathology, both in cell culture and in animal models. This review explores a range of host pathways and drugs, some already approved for clinical use that have the potential to provide new adjunctive therapies for tuberculosis. Drugs targeting host processes may largely avoid the development of bacterial antibiotic resistance, a major public health concern for tuberculosis. However, these drugs may also have generally increased risk for side effects on the host. Understanding the specific mechanisms by which these drugs act and the relationship of these mechanisms to Mycobacterium tuberculosis pathogenesis will be critical in selecting appropriate host-directed therapy. Overall, these host-directed compounds provide a novel strategy for antituberculosis therapy.

Citing Articles

Tax1bp1 enhances bacterial virulence and promotes inflammatory responses during infection of alveolar macrophages.

Chin J, Abeydeera N, Repasy T, Rivera-Lugo R, Mitchell G, Nguyen V bioRxiv. 2025; .

PMID: 39763950 PMC: 11702572. DOI: 10.1101/2024.12.16.628616.

Cellular and Molecular Network Characteristics of -Related Genes in Infections.

Peng L, Wu H, Zhu L, Song J, Ma W, Zhong L Int J Mol Sci. 2024; 25(18).

PMID: 39337585 PMC: 11432409. DOI: 10.3390/ijms251810100.

The aryl hydrocarbon receptor and FOS mediate cytotoxicity induced by Acinetobacter baumannii.

Kew C, Prieto-Garcia C, Bhattacharya A, Tietgen M, MacNair C, Carfrae L Nat Commun. 2024; 15(1):7939.

PMID: 39261458 PMC: 11390868. DOI: 10.1038/s41467-024-52118-7.

Leveraging insights from cancer to improve tuberculosis therapy.

Datta M, Via L, Dartois V, Xu L, Barry 3rd C, Jain R Trends Mol Med. 2024; 31(1):11-20.

PMID: 39142973 PMC: 11717643. DOI: 10.1016/j.molmed.2024.07.011.

Indoleamine-2,3-dioxygenase inhibition improves immunity and is safe for concurrent use with cART during Mtb/SIV coinfection.

Singh B, Sharan R, Ravichandran G, Escobedo R, Shivanna V, Dick Jr E JCI Insight. 2024; 9(15).

PMID: 39114981 PMC: 11383603. DOI: 10.1172/jci.insight.179317.

References

Johnson B, Bekker L, Rickman R, Brown S, Lesser M, Ress S . rhuIL-2 adjunctive therapy in multidrug resistant tuberculosis: a comparison of two treatment regimens and placebo. Tuber Lung Dis. 1997; 78(3-4):195-203. DOI: 10.1016/s0962-8479(97)90026-5. View

Eum S, Kong J, Hong M, Lee Y, Kim J, Hwang S . Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB. Chest. 2009; 137(1):122-8. PMC: 2803122. DOI: 10.1378/chest.09-0903. View

Berry M, Graham C, McNab F, Xu Z, Bloch S, Oni T . An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature. 2010; 466(7309):973-7. PMC: 3492754. DOI: 10.1038/nature09247. View

Marais S, Wilkinson R, Pepper D, Meintjes G . Management of patients with the immune reconstitution inflammatory syndrome. Curr HIV/AIDS Rep. 2009; 6(3):162-71. DOI: 10.1007/s11904-009-0022-z. View

Mayosi B, Ntsekhe M, Volmink J, Commerford P . Interventions for treating tuberculous pericarditis. Cochrane Database Syst Rev. 2003; (4):CD000526. DOI: 10.1002/14651858.CD000526. View

Schoeman J, Springer P, Van Rensburg A, Swanevelder S, Hanekom W, Haslett P . Adjunctive thalidomide therapy for childhood tuberculous meningitis: results of a randomized study. J Child Neurol. 2004; 19(4):250-7. DOI: 10.1177/088307380401900402. View

Singh S, Davis A, Taylor G, Deretic V . Human IRGM induces autophagy to eliminate intracellular mycobacteria. Science. 2006; 313(5792):1438-41. DOI: 10.1126/science.1129577. View

Wejse C, Olesen R, Rabna P, Kaestel P, Gustafson P, Aaby P . Serum 25-hydroxyvitamin D in a West African population of tuberculosis patients and unmatched healthy controls. Am J Clin Nutr. 2007; 86(5):1376-83. DOI: 10.1093/ajcn/86.5.1376. View

Kim J, Scialli A . Thalidomide: the tragedy of birth defects and the effective treatment of disease. Toxicol Sci. 2011; 122(1):1-6. DOI: 10.1093/toxsci/kfr088. View

10.

Pan H, Yan B, Rojas M, Shebzukhov Y, Zhou H, Kobzik L . Ipr1 gene mediates innate immunity to tuberculosis. Nature. 2005; 434(7034):767-72. PMC: 1388092. DOI: 10.1038/nature03419. View

11.

Flynn J . Lessons from experimental Mycobacterium tuberculosis infections. Microbes Infect. 2006; 8(4):1179-88. DOI: 10.1016/j.micinf.2005.10.033. View

12.

Subbian S, Tsenova L, OBrien P, Yang G, Koo M, Peixoto B . Phosphodiesterase-4 inhibition combined with isoniazid treatment of rabbits with pulmonary tuberculosis reduces macrophage activation and lung pathology. Am J Pathol. 2011; 179(1):289-301. PMC: 3123788. DOI: 10.1016/j.ajpath.2011.03.039. View

13.

Vilaplana C, Marzo E, Tapia G, Diaz J, Garcia V, Cardona P . Ibuprofen therapy resulted in significantly decreased tissue bacillary loads and increased survival in a new murine experimental model of active tuberculosis. J Infect Dis. 2013; 208(2):199-202. DOI: 10.1093/infdis/jit152. View

14.

Nursyam E, Amin Z, Rumende C . The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med Indones. 2006; 38(1):3-5. View

15.

Fabri M, Stenger S, Shin D, Yuk J, Liu P, Realegeno S . Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages. Sci Transl Med. 2011; 3(104):104ra102. PMC: 3269210. DOI: 10.1126/scitranslmed.3003045. View

16.

Wilkinson R, Llewelyn M, Toossi Z, Patel P, Pasvol G, Lalvani A . Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet. 2000; 355(9204):618-21. DOI: 10.1016/S0140-6736(99)02301-6. View

17.

Watson R, Manzanillo P, Cox J . Extracellular M. tuberculosis DNA targets bacteria for autophagy by activating the host DNA-sensing pathway. Cell. 2012; 150(4):803-15. PMC: 3708656. DOI: 10.1016/j.cell.2012.06.040. View

18.

Nandi B, Behar S . Regulation of neutrophils by interferon-γ limits lung inflammation during tuberculosis infection. J Exp Med. 2011; 208(11):2251-62. PMC: 3201199. DOI: 10.1084/jem.20110919. View

19.

Taylor J, Hattle J, Dreitz S, Troudt J, Izzo L, Basaraba R . Role for matrix metalloproteinase 9 in granuloma formation during pulmonary Mycobacterium tuberculosis infection. Infect Immun. 2006; 74(11):6135-44. PMC: 1695484. DOI: 10.1128/IAI.02048-05. View

20.

Shoji-Kawata S, Sumpter R, Leveno M, Campbell G, Zou Z, Kinch L . Identification of a candidate therapeutic autophagy-inducing peptide. Nature. 2013; 494(7436):201-6. PMC: 3788641. DOI: 10.1038/nature11866. View